The Surge of the Indian
Pharmaceutical Sector
The Indian domestic pharma market is
estimated at Rs 90,400 crore (US$ 15 bn) ending FY15 with a growth of 12 per
cent. It is estimated that almost 27-30 per cent of India's pharmaceutical market
is catered to by multinationals operating in India and around 460,000 people
are estimated to be employed in the pharmaceutical industry.
The top 20 companies account for 64 per cent of the market. 8 out
of the top 20 are growing faster than the market, with Macleoids topping the
list with 23.4 per cent growth followed by Intas with 21.3 per cent, Cipla 19.7
per cent, Glenmark over 19.4 per cent growth and Mankind 19.3 per cent.
Besides, India's pharma exports stood at US$ 15.3 billion in 2014-15. There
were M&A activities in the industry that accounted for $ 5.78 bn, an
increase of around 44.5 per cent in comparison to 2013.
The Government's continuous and concerted efforts have resulted in
the reach of modern medicine to almost all corners of the country, and its
measures have resulted in the steady decline of communicable diseases. The
successful eradication of polio, small pox, etc can be attributed entirely to
the tireless efforts of the Government. The Ministry of Health and Family
Welfare is responsible for the implementation of national health and family
welfare programs such as the prevention and control of major communicable
diseases, maternal and child health.
https://www.process-worldwide.com/index.cfm?pid=10182&pk=508279&cmp=nl-315
No comments:
Post a Comment